Mirae Asset Global Etfs Holdings Ltd. Agios Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,579 shares of AGIO stock, worth $1.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,579
Previous 43,327
8.65%
Holding current value
$1.6 Million
Previous $1.27 Million
3.7%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AGIO
# of Institutions
235Shares Held
61.8MCall Options Held
297KPut Options Held
235K-
Farallon Capital Management LLC San Francisco, CA5.77MShares$234 Million0.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.68MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$197 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.59MShares$145 Million2.72% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.33MShares$94.2 Million0.65% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.22B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...